
|Articles|May 23, 2011
Petri Dish RSS
Advertisement
Advertisement
Related Content
Advertisement

ByPatrick Neven, MD, PhD,Andre Mattar,Antonio Llombart-Cussac,Giuseppe Curigliano,Nadia Harbeck, MD, PhD,Joyce O’Shaughnessy, MD,François-Clément Bidard,Monica Lis Casalnuovo,Sung-Bae Kim,Eriko Tokunaga,Cristina Saura,Lisa A. Carey, MD,Kamnesh R. Pradhan,Shanshan Cao,Monique Coersmeyer,Anna Emde,Francisco Sapunar,Komal L. Jhaveri,Philippe Aftimos




Advertisement
Advertisement
Trending on CancerNetwork
1
Concomitant COVID-19 Vaccination Tied to Improved OS with Immunotherapy
2
Navigating CAR T-Cell Therapy Use as a “Team Sport” in Multiple Myeloma
3
FDA Approves FoundationOne CDx for Tepotinib in MET+ NSCLC
4
Sacituzumab Tirumotecan Meets PFS End Point as 1L Option in Advanced TNBC
5
























































